首页 > 最新文献

Kurume Medical Journal最新文献

英文 中文
The Difference in Clinical Features between Small-Sized Soft Tissue Sarcomas and Benign Tumors. 小型软组织肉瘤与良性肿瘤临床特征的差异。
Q4 Medicine Pub Date : 2023-11-30 Epub Date: 2023-10-03 DOI: 10.2739/kurumemedj.MS69120015
Keiichiro Iida, Yoshihiro Matsumoto, Akira Nabeshima, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yasuharu Nakashima

Background: Small-sized tumors tend to be resected without thorough assessment and are often managed in a sarcoma center after a malignancy is diagnosed. The lack of knowledge about the features of smallsized sarcomas may lead to unplanned resection. The features of small-sized soft tissue sarcomas were investigated by comparing them with those of small benign soft tissue tumors.

Methods: We included 17 soft tissue sarcoma cases (7 on the hands and feet and 10 on the limbs and trunk) with a diameter of under 2 cm. The features of small-sized sarcomas were compared to those of 39 benign soft tissue tumors with a diameter of under 2 cm and non-specific imaging findings (30 on the hands and feet and 9 on the limbs and trunk). The investigated features were age, sex, presence of pain, subjective increasing tumor size, and duration of observation.

Results: When we compared the tumors in the hands and feet, those <40 years of age (5/7 [71%] vs. 8/30 [27%], p=0.03) experiencing pain (7/7 [100%] vs. 13/30 [43%], p=0.007) were more common in patients with sarcomas than in patients with benign tumors. When we compared the tumors in the limbs and trunk, there was no significant difference in all investigated features.

Conclusion: Although clinical features were ineffective in distinguishing malignancy in most small-sized soft tissue tumors, we should pay attention to painful tumors of the hands and feet in younger patients.

背景:小肿瘤往往在没有彻底评估的情况下被切除,并且通常在诊断出恶性肿瘤后在肉瘤中心进行治疗。对小型肉瘤的特征缺乏了解可能导致计划外切除。通过与小型良性软组织肿瘤的比较,探讨了小型软组织肉瘤的特点。方法:我们纳入了17例直径小于2cm的软组织肉瘤(7例在手和脚上,10例在四肢和躯干上)。将小型肉瘤的特征与39例直径小于2cm的良性软组织肿瘤和非特异性影像学表现(30例在手脚上,9例在四肢或躯干上)的特征进行比较。研究的特征包括年龄、性别、疼痛的存在、主观上肿瘤大小的增加和观察的持续时间。结果:当我们比较手和脚的肿瘤时,这些结论:尽管临床特征不能区分大多数小型软组织肿瘤的恶性程度,但我们应该注意年轻患者的手和脚疼痛肿瘤。
{"title":"The Difference in Clinical Features between Small-Sized Soft Tissue Sarcomas and Benign Tumors.","authors":"Keiichiro Iida, Yoshihiro Matsumoto, Akira Nabeshima, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yasuharu Nakashima","doi":"10.2739/kurumemedj.MS69120015","DOIUrl":"10.2739/kurumemedj.MS69120015","url":null,"abstract":"<p><strong>Background: </strong>Small-sized tumors tend to be resected without thorough assessment and are often managed in a sarcoma center after a malignancy is diagnosed. The lack of knowledge about the features of smallsized sarcomas may lead to unplanned resection. The features of small-sized soft tissue sarcomas were investigated by comparing them with those of small benign soft tissue tumors.</p><p><strong>Methods: </strong>We included 17 soft tissue sarcoma cases (7 on the hands and feet and 10 on the limbs and trunk) with a diameter of under 2 cm. The features of small-sized sarcomas were compared to those of 39 benign soft tissue tumors with a diameter of under 2 cm and non-specific imaging findings (30 on the hands and feet and 9 on the limbs and trunk). The investigated features were age, sex, presence of pain, subjective increasing tumor size, and duration of observation.</p><p><strong>Results: </strong>When we compared the tumors in the hands and feet, those <40 years of age (5/7 [71%] vs. 8/30 [27%], p=0.03) experiencing pain (7/7 [100%] vs. 13/30 [43%], p=0.007) were more common in patients with sarcomas than in patients with benign tumors. When we compared the tumors in the limbs and trunk, there was no significant difference in all investigated features.</p><p><strong>Conclusion: </strong>Although clinical features were ineffective in distinguishing malignancy in most small-sized soft tissue tumors, we should pay attention to painful tumors of the hands and feet in younger patients.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"65-73"},"PeriodicalIF":0.0,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41177224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary Clinical Experience with a High-Definition Three Dimensional Exoscope for Spinal Surgery. 脊柱外科高清晰度三维外窥镜的初步临床经验。
Q4 Medicine Pub Date : 2023-11-30 Epub Date: 2023-10-03 DOI: 10.2739/kurumemedj.MS6912011
Kimiaki Sato, Kimiaki Yokosuka, Tatsuhiro Yoshida, Takahiro Shimazaki, Rikiya Saruwatari, Kota Nishida, Atsushi Matsuo, Shinji Morito, Takuma Fudo, Masafumi Goto, Tsunemasa Matsubara, Kei Yamada, Naoto Shiba

We retrospectively evaluated spinal surgeries performed using the high-definition three-dimensional exoscopic system, which became available at our institution in August 2020. Eleven patients (4 with cervical disease and 7 with lumbar disease) underwent surgery with the system. There were no surgical complications related to the system, and the results were satisfactory. The small, flexible camera of the exoscope allows the surgeon to view the surgical field from various angles, facilitating both the approach and technique. In addition, it allows the surgeon to operate in an upright position without strain on the head and neck. Although further surgical experience is needed, this system has the potential to improve the visualization of the surgical field in spinal surgery.

我们回顾性评估了使用高清三维外窥镜系统进行的脊柱手术,该系统于2020年8月在我们机构上市。11名患者(4名患有宫颈疾病,7名患有腰椎疾病)接受了该系统的手术。没有与该系统相关的手术并发症,结果令人满意。外窥镜的小而灵活的摄像头使外科医生能够从不同角度观察手术区域,方便了手术方法和技术。此外,它允许外科医生以直立的姿势进行手术,而不会对头部和颈部造成压力。尽管还需要进一步的手术经验,但该系统有可能改善脊柱外科手术领域的可视化。
{"title":"Preliminary Clinical Experience with a High-Definition Three Dimensional Exoscope for Spinal Surgery.","authors":"Kimiaki Sato, Kimiaki Yokosuka, Tatsuhiro Yoshida, Takahiro Shimazaki, Rikiya Saruwatari, Kota Nishida, Atsushi Matsuo, Shinji Morito, Takuma Fudo, Masafumi Goto, Tsunemasa Matsubara, Kei Yamada, Naoto Shiba","doi":"10.2739/kurumemedj.MS6912011","DOIUrl":"10.2739/kurumemedj.MS6912011","url":null,"abstract":"<p><p>We retrospectively evaluated spinal surgeries performed using the high-definition three-dimensional exoscopic system, which became available at our institution in August 2020. Eleven patients (4 with cervical disease and 7 with lumbar disease) underwent surgery with the system. There were no surgical complications related to the system, and the results were satisfactory. The small, flexible camera of the exoscope allows the surgeon to view the surgical field from various angles, facilitating both the approach and technique. In addition, it allows the surgeon to operate in an upright position without strain on the head and neck. Although further surgical experience is needed, this system has the potential to improve the visualization of the surgical field in spinal surgery.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"47-51"},"PeriodicalIF":0.0,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41147288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difficulty in the Diagnosis of Biliary Atresia Splenic Malformation Syndrome In Utero. 子宫胆道闭锁-脾畸形综合征的诊断困难。
Q4 Medicine Pub Date : 2023-09-25 Epub Date: 2023-06-29 DOI: 10.2739/kurumemedj.MS6834011
Kunio So, Takaaki Shinagawa, Toshiyuki Yoshizato, Suguru Fukahori, Kimio Asagiri, Yasuki Maeno, Shintaro Hayashida, Kimio Ushijima

The fetus of a 30-year-old pregnant Japanese woman was diagnosed with absence of inferior vena cava (IVC) and azygos continuation of interrupted IVC without cardiac anomalies at 34 weeks of gestation, and a healthy male neonate weighing 2,910 g was delivered at 37 weeks of gestation. On day 42 after birth, direct bilirubin predominant hyperbilirubinemia and high serum gamma-GTP levels were detected. Computed tomography revealed the presence of a lobulated and accessory spleen, and laparotomy demonstrated type III biliary atresia (BA), confirming the final diagnosis of BA splenic malformation (BASM) syndrome. In retrospect, non-visualization of the gallbladder was missed in utero. The combination of the absence of IVC and BA without cardiac anomalies is far less likely to occur in left isomerism. Although BA remains difficult to detect in utero, special attention should be paid to cases of BA associated with findings of left isomerism, including the absence of IVC, to enable early diagnosis and treatment of BASM.

一名30岁的日本孕妇的胎儿在妊娠34周时被诊断为下腔静脉(IVC)缺失和奇静脉持续中断,没有心脏异常,一名健康的男性新生儿在妊娠37周时分娩,体重2910克。在出生后第42天,检测到直接胆红素为主的高胆红素血症和高血清γ-GTP水平。计算机断层扫描显示存在分叶和副脾,剖腹探查显示III型胆道闭锁(BA),证实了BA脾脏畸形(BASM)综合征的最终诊断。回顾过去,在子宫内未发现胆囊。没有IVC和BA而没有心脏异常的组合在左异构体中发生的可能性要小得多。尽管BA在子宫内仍然很难检测到,但应特别注意与左侧异构体发现相关的BA病例,包括IVC的缺失,以实现BASM的早期诊断和治疗。
{"title":"Difficulty in the Diagnosis of Biliary Atresia Splenic Malformation Syndrome In Utero.","authors":"Kunio So,&nbsp;Takaaki Shinagawa,&nbsp;Toshiyuki Yoshizato,&nbsp;Suguru Fukahori,&nbsp;Kimio Asagiri,&nbsp;Yasuki Maeno,&nbsp;Shintaro Hayashida,&nbsp;Kimio Ushijima","doi":"10.2739/kurumemedj.MS6834011","DOIUrl":"10.2739/kurumemedj.MS6834011","url":null,"abstract":"<p><p>The fetus of a 30-year-old pregnant Japanese woman was diagnosed with absence of inferior vena cava (IVC) and azygos continuation of interrupted IVC without cardiac anomalies at 34 weeks of gestation, and a healthy male neonate weighing 2,910 g was delivered at 37 weeks of gestation. On day 42 after birth, direct bilirubin predominant hyperbilirubinemia and high serum gamma-GTP levels were detected. Computed tomography revealed the presence of a lobulated and accessory spleen, and laparotomy demonstrated type III biliary atresia (BA), confirming the final diagnosis of BA splenic malformation (BASM) syndrome. In retrospect, non-visualization of the gallbladder was missed in utero. The combination of the absence of IVC and BA without cardiac anomalies is far less likely to occur in left isomerism. Although BA remains difficult to detect in utero, special attention should be paid to cases of BA associated with findings of left isomerism, including the absence of IVC, to enable early diagnosis and treatment of BASM.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"265-268"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9694700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Duplication of the Hypoglossal Nerve Branch to the Thyrohyoid Muscle: A Case Report. 舌下神经分支与甲状腺肌的重复:一例报告。
Q4 Medicine Pub Date : 2023-09-25 Epub Date: 2023-06-12 DOI: 10.2739/kurumemedj.MS6834002
Craig Ballard, Grzegorz Wysiadecki, Jerzy A Walocha, R Shane Tubbs, Joe Iwanaga

The motor fibers to the thyrohyoid muscle are provided by the anterior ramus of C1 via the hypoglossal nerve rather than via the ansa cervicalis. Knowledge of possible variations in the branching patterns of the nerves attached to the hypoglossal nerve is necessary to minimize iatrogenic injury to these structures during surgical procedures. We describe a rare anatomical variant of the nerve branch to the thyrohyoid muscle. To our knowledge, this particular variant has not been previously reported.

甲状舌骨肌的运动纤维由C1的前支通过舌下神经而不是通过颈安肌提供。了解附着在舌下神经上的神经分支模式的可能变化,对于最大限度地减少手术过程中对这些结构的医源性损伤是必要的。我们描述了一种罕见的甲状腺舌骨肌神经分支的解剖学变异。据我们所知,这种特殊的变体以前没有报道过。
{"title":"Duplication of the Hypoglossal Nerve Branch to the Thyrohyoid Muscle: A Case Report.","authors":"Craig Ballard,&nbsp;Grzegorz Wysiadecki,&nbsp;Jerzy A Walocha,&nbsp;R Shane Tubbs,&nbsp;Joe Iwanaga","doi":"10.2739/kurumemedj.MS6834002","DOIUrl":"10.2739/kurumemedj.MS6834002","url":null,"abstract":"<p><p>The motor fibers to the thyrohyoid muscle are provided by the anterior ramus of C1 via the hypoglossal nerve rather than via the ansa cervicalis. Knowledge of possible variations in the branching patterns of the nerves attached to the hypoglossal nerve is necessary to minimize iatrogenic injury to these structures during surgical procedures. We describe a rare anatomical variant of the nerve branch to the thyrohyoid muscle. To our knowledge, this particular variant has not been previously reported.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"247-250"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9614659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cone-Beam Computed Tomography-Guided Marking of Small Pulmonary Nodules with Surgical Clips. 锥形束计算机断层扫描引导下用手术夹标记肺部小结节。
Q4 Medicine Pub Date : 2023-09-25 Epub Date: 2023-06-14 DOI: 10.2739/kurumemedj.MS6834006
Masahiro Mitsuoka, Masaki Kashihara, Tatsuya Nishi, Koichi Yoshiyama, Toshihiro Hashiguchi, Shintaro Yokoyama, Daigo Murakami, Fumihiko Fujita, Shinzo Takamori, Yoshito Akagi
BACKGROUNDPreoperative computed tomography-guided marking can help identify small non-palpable pulmonary nodules during surgery. However, this technique is associated with the risk of air embolism. We retrospectively evaluated whether small pulmonary nodules could be intraoperatively localized using cone-beam computed tomography (CBCT).METHODSA hybrid operating room permitting stable lateral positioning and scanning from the pulmonary apex to the base was used in all patients. CBCT images were obtained using a 10-s protocol with 180º rotation of the C-arm flat panel detector around the patient. Clips were placed on the visceral pleura to help guide pulmonary nodule localization. Partial pulmonary resection was performed using video-assisted thoracoscopic surgery at the predicted nodule site.RESULTSBetween July 2013 and June 2019, 132 patients with 145 lesions underwent this procedure at our center. The detection rate of lesions on CBCT was 100%. The pathological diagnoses were primary lung cancer, metastatic pulmonary tumors, and benign lesions. The average consolidation-to-tumor ratio was 0.65 for all nodules, with ratios of 0.33, 0.96, and 0.70 for primary lung cancer, metastatic pulmonary tumors, and benign lesions, respectively. No complications related to this localization method were observed.CONCLUSIONSCBCT-guided intraoperative localization is safe and feasible for non-palpable small pulmonary nodules. This technique may eliminate the risk of serious complications such as air embolism.
背景:术前计算机断层扫描引导下的标记可以帮助识别手术中无法触及的小肺结节。然而,这种技术与空气栓塞的风险有关。我们回顾性地评估了是否可以使用锥形束计算机断层扫描(CBCT)在手术中定位肺部小结节。方法:所有患者都使用了一个混合手术室,允许稳定的横向定位和从肺尖到基底的扫描。CBCT图像是使用10s方案获得的,C臂平板探测器在患者周围旋转180º。在内脏胸膜上放置夹子,以帮助指导肺结节的定位。在预测的结节部位使用电视胸腔镜进行部分肺切除术。结果:2013年7月至2019年6月,我们中心共有132名患者接受了该手术,共145处病变。CBCT对病变的检出率为100%。病理诊断为原发性肺癌、转移性肺肿瘤和良性病变。所有结节的平均巩固率为0.65,原发性癌症、转移性肺肿瘤和良性病变的巩固率分别为0.33、0.96和0.70。未观察到与该定位方法相关的并发症。结论:CBCT引导下的肺小结节术中定位是安全可行的。这种技术可以消除严重并发症(如空气栓塞)的风险。
{"title":"Cone-Beam Computed Tomography-Guided Marking of Small Pulmonary Nodules with Surgical Clips.","authors":"Masahiro Mitsuoka,&nbsp;Masaki Kashihara,&nbsp;Tatsuya Nishi,&nbsp;Koichi Yoshiyama,&nbsp;Toshihiro Hashiguchi,&nbsp;Shintaro Yokoyama,&nbsp;Daigo Murakami,&nbsp;Fumihiko Fujita,&nbsp;Shinzo Takamori,&nbsp;Yoshito Akagi","doi":"10.2739/kurumemedj.MS6834006","DOIUrl":"10.2739/kurumemedj.MS6834006","url":null,"abstract":"BACKGROUND\u0000Preoperative computed tomography-guided marking can help identify small non-palpable pulmonary nodules during surgery. However, this technique is associated with the risk of air embolism. We retrospectively evaluated whether small pulmonary nodules could be intraoperatively localized using cone-beam computed tomography (CBCT).\u0000\u0000\u0000METHODS\u0000A hybrid operating room permitting stable lateral positioning and scanning from the pulmonary apex to the base was used in all patients. CBCT images were obtained using a 10-s protocol with 180º rotation of the C-arm flat panel detector around the patient. Clips were placed on the visceral pleura to help guide pulmonary nodule localization. Partial pulmonary resection was performed using video-assisted thoracoscopic surgery at the predicted nodule site.\u0000\u0000\u0000RESULTS\u0000Between July 2013 and June 2019, 132 patients with 145 lesions underwent this procedure at our center. The detection rate of lesions on CBCT was 100%. The pathological diagnoses were primary lung cancer, metastatic pulmonary tumors, and benign lesions. The average consolidation-to-tumor ratio was 0.65 for all nodules, with ratios of 0.33, 0.96, and 0.70 for primary lung cancer, metastatic pulmonary tumors, and benign lesions, respectively. No complications related to this localization method were observed.\u0000\u0000\u0000CONCLUSIONS\u0000CBCT-guided intraoperative localization is safe and feasible for non-palpable small pulmonary nodules. This technique may eliminate the risk of serious complications such as air embolism.","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"183-189"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9630286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical Trial. 潜在可切除UICC7 IIIA、IIIB期肝细胞癌术前化疗后肝切除术;二期临床试验。
Q4 Medicine Pub Date : 2023-09-25 Epub Date: 2023-07-28 DOI: 10.2739/kurumemedj.MS6834010
Yuichi Goto, Takashi Niizeki, Shogo Fukutomi, Tomotake Shirono, Shigeo Shimose, Hideki Iwamoto, Satoki Kojima, Hiroki Kanno, Yoshihiro Uchino, Shin Sasaki, Nobuhisa Shirahama, Daisuke Muroya, Yoriko Nomura, Masanori Akashi, Goichi Nakayama, Yusuke Hirakawa, Toshihiro Sato, Munehiro Yoshitomi, Hisamune Sakai, Toru Hisaka, Tatsuyuki Kakuma, Hironori Koga, Takuji Torimura, Yoshito Akagi, Koji Okuda

Background: The Japanese guideline for therapeutic strategy in HCC does not recognize any benefit of preoperative chemotherapy for potentially resectable hepatocellular carcinoma (HCC), and only upfront resec tion is recommended even for an advanced HCC. Data on preoperative chemotherapy for advanced HCC is still limited. Poor prognostic factors of HCC after resection are tumor more than 5 cm in diameter, multiple lesions, and gross tumor thrombosis, which constitute UICC7 Stage IIIA and IIIB HCC. There are no prospective studies about preoperative chemotherapy in these patients.

Aim: To evaluate the benefit of preoperative chemotherapy for UICC7 Stage IIIA and IIIB potentially resectable HCC.

Discussion: Our recent study demonstrated that the 5-year overall survival rate (OS) of patients diagnosed as UICC7 Stage IIIA and IIIB who had received upfront resection was only 16.5%. In contrast, the 5-year OS of UICC7 Stage IIIA and IIIB initially unresectable patients who had achieved conversion from unresectable to resect able status under successful hepatic infusion chemotherapy prior to resection was as high as 61.3%. Additionally, recent studies reported transarterial chemoembolization achieved outcomes comparable with those of resection. Therefore, we believe that patients with UICC7 Stage IIIA and IIIB should be considered borderline resectable. To evaluate this hypothesis we registered the present phase II clinical trial to assess the benefit of preoperative chemo therapy followed by hepatectomy in potentially resectable UICC7 Stage IIIA and IIIB HCC patients.

背景:日本的HCC治疗策略指南没有认识到术前化疗对潜在可切除的肝细胞癌(HCC)有任何益处,即使是晚期HCC,也只建议提前化疗。关于晚期HCC术前化疗的数据仍然有限。切除后HCC的不良预后因素是直径超过5cm的肿瘤、多发性病变和严重的肿瘤血栓形成,这构成了UICC7 IIIA和IIIB期HCC。目前尚无关于这些患者术前化疗的前瞻性研究。目的:评估术前化疗对UICC7 IIIA和IIIB期潜在可切除HCC的益处。讨论:我们最近的研究表明,接受前期切除的UICC7 III A和III B期患者的5年总生存率(OS)仅为16.5%。相反,UICC7 IIIA期和IIIB期最初不可切除的患者,在切除前成功的肝脏输注化疗下从不可切除状态转变为可切除状态的5年OS高达61.3%。此外,最近的研究报告称,经动脉化疗栓塞的结果与切除相当。因此,我们认为UICC7 IIIA和IIIB期患者应被视为可边缘切除。为了评估这一假设,我们注册了目前的II期临床试验,以评估术前化疗后肝切除术对可能可切除的UICC7 IIIA和IIIB期HCC患者的益处。
{"title":"Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical Trial.","authors":"Yuichi Goto,&nbsp;Takashi Niizeki,&nbsp;Shogo Fukutomi,&nbsp;Tomotake Shirono,&nbsp;Shigeo Shimose,&nbsp;Hideki Iwamoto,&nbsp;Satoki Kojima,&nbsp;Hiroki Kanno,&nbsp;Yoshihiro Uchino,&nbsp;Shin Sasaki,&nbsp;Nobuhisa Shirahama,&nbsp;Daisuke Muroya,&nbsp;Yoriko Nomura,&nbsp;Masanori Akashi,&nbsp;Goichi Nakayama,&nbsp;Yusuke Hirakawa,&nbsp;Toshihiro Sato,&nbsp;Munehiro Yoshitomi,&nbsp;Hisamune Sakai,&nbsp;Toru Hisaka,&nbsp;Tatsuyuki Kakuma,&nbsp;Hironori Koga,&nbsp;Takuji Torimura,&nbsp;Yoshito Akagi,&nbsp;Koji Okuda","doi":"10.2739/kurumemedj.MS6834010","DOIUrl":"10.2739/kurumemedj.MS6834010","url":null,"abstract":"<p><strong>Background: </strong>The Japanese guideline for therapeutic strategy in HCC does not recognize any benefit of preoperative chemotherapy for potentially resectable hepatocellular carcinoma (HCC), and only upfront resec tion is recommended even for an advanced HCC. Data on preoperative chemotherapy for advanced HCC is still limited. Poor prognostic factors of HCC after resection are tumor more than 5 cm in diameter, multiple lesions, and gross tumor thrombosis, which constitute UICC7 Stage IIIA and IIIB HCC. There are no prospective studies about preoperative chemotherapy in these patients.</p><p><strong>Aim: </strong>To evaluate the benefit of preoperative chemotherapy for UICC7 Stage IIIA and IIIB potentially resectable HCC.</p><p><strong>Discussion: </strong>Our recent study demonstrated that the 5-year overall survival rate (OS) of patients diagnosed as UICC7 Stage IIIA and IIIB who had received upfront resection was only 16.5%. In contrast, the 5-year OS of UICC7 Stage IIIA and IIIB initially unresectable patients who had achieved conversion from unresectable to resect able status under successful hepatic infusion chemotherapy prior to resection was as high as 61.3%. Additionally, recent studies reported transarterial chemoembolization achieved outcomes comparable with those of resection. Therefore, we believe that patients with UICC7 Stage IIIA and IIIB should be considered borderline resectable. To evaluate this hypothesis we registered the present phase II clinical trial to assess the benefit of preoperative chemo therapy followed by hepatectomy in potentially resectable UICC7 Stage IIIA and IIIB HCC patients.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"239-245"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9899807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Surgical Site Infection in Spinal Surgery and Interventions: A Retrospective Study. 脊柱外科手术和介入治疗中手术部位感染的危险因素:一项回顾性研究。
Q4 Medicine Pub Date : 2023-09-25 Epub Date: 2023-06-14 DOI: 10.2739/kurumemedj.MS6834004
Rikiya Saruwatari, Kei Yamada, Kimiaki Sato, Kimiaki Yokosuka, Tatsuhiro Yoshida, Ichiro Nakae, Takahiro Shimazaki, Shinji Morito, Naoto Shiba

Background: Surgical site infection following spinal surgery causes prolonged delay in recovery after surgery, increases cost, and sometimes leads to additional surgical procedures. We investigated risk factors for the occurrence of surgical site infection events in terms of patient-related, surgery-related, and postoperative factors.

Methods: This retrospective study included 1000 patients who underwent spinal surgery in our hospital between April 2016 and March 2019.

Results: Patient-related factors were dementia, length of preoperative hospital stay (≥ 14 days), and diagnosis at the time of surgery (traumatic injury or deformity). The one surgery-related factor was multilevel surgery (≥ 9 intervertebral levels), and the one postoperative factor was time to ambulation (≥ 7 days) were statistically significant risk factors for spinal surgical site infection.

Conclusion: One risk factor identified in this study that is amenable to intervention is time to ambulation. As delayed ambulation is a risk factor for postoperative surgical site infection, how medical staff can intervene in postoperative ambulation to further reduce the incidence of surgical site infection is a topic for future research.

背景:脊柱手术后的手术部位感染会导致术后恢复延迟,增加成本,有时还会导致额外的手术程序。我们从患者相关、手术相关和术后因素方面调查了手术部位感染事件发生的风险因素。方法:本回顾性研究纳入了2016年4月至2019年3月在我院接受脊柱手术的1000名患者。结果:患者相关因素为痴呆、术前住院时间(≥14天)和手术时的诊断(创伤性损伤或畸形)。一个手术相关因素是多级手术(≥9个椎间水平),一个手术后因素是活动时间(≥7天),这是脊柱手术部位感染的统计学显著危险因素。结论:本研究中确定的一个可干预的风险因素是行走时间。由于延迟行走是术后手术部位感染的危险因素,医护人员如何干预术后行走,进一步降低手术部位感染发生率是未来研究的课题。
{"title":"Risk Factors for Surgical Site Infection in Spinal Surgery and Interventions: A Retrospective Study.","authors":"Rikiya Saruwatari,&nbsp;Kei Yamada,&nbsp;Kimiaki Sato,&nbsp;Kimiaki Yokosuka,&nbsp;Tatsuhiro Yoshida,&nbsp;Ichiro Nakae,&nbsp;Takahiro Shimazaki,&nbsp;Shinji Morito,&nbsp;Naoto Shiba","doi":"10.2739/kurumemedj.MS6834004","DOIUrl":"10.2739/kurumemedj.MS6834004","url":null,"abstract":"<p><strong>Background: </strong>Surgical site infection following spinal surgery causes prolonged delay in recovery after surgery, increases cost, and sometimes leads to additional surgical procedures. We investigated risk factors for the occurrence of surgical site infection events in terms of patient-related, surgery-related, and postoperative factors.</p><p><strong>Methods: </strong>This retrospective study included 1000 patients who underwent spinal surgery in our hospital between April 2016 and March 2019.</p><p><strong>Results: </strong>Patient-related factors were dementia, length of preoperative hospital stay (≥ 14 days), and diagnosis at the time of surgery (traumatic injury or deformity). The one surgery-related factor was multilevel surgery (≥ 9 intervertebral levels), and the one postoperative factor was time to ambulation (≥ 7 days) were statistically significant risk factors for spinal surgical site infection.</p><p><strong>Conclusion: </strong>One risk factor identified in this study that is amenable to intervention is time to ambulation. As delayed ambulation is a risk factor for postoperative surgical site infection, how medical staff can intervene in postoperative ambulation to further reduce the incidence of surgical site infection is a topic for future research.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"201-207"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9630285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Double Inferior Vena Cava with Major Predominance of the Left Inferior Vena Cava: A Cadaver Case Report. 以左下腔静脉为主的双下腔静脉:一例死亡病例报告。
Q4 Medicine Pub Date : 2023-09-25 Epub Date: 2023-06-29 DOI: 10.2739/kurumemedj.MS6834013
Yoko Tabira, Tsuyoshi Saga, Joe Iwanaga, Akihiro Yamashita, Aya Han, Yuto Haikata, Keishiro Kikuchi, Kunimitsu Nooma, Eiko Inoue, Koichi Watanabe

We encountered a case of a double inferior vena cava with major predominance of the left inferior vena cava during an anatomical dissection course for medical students in 2015. The right inferior vena cava (normal inferior vena cava) was 2.0 mm wide, and the left inferior vena cava was 23.2 mm wide. The fine right inferior vena cava began at the right common iliac vein, ascended along the right side of the abdominal aorta, and then joined the left inferior vena cava at the level of the lower margin of the first lumbar vertebra. The dominant left inferior vena cava started from the left common iliac vein and ascended along the left side of the abdominal aorta. Most patients with a double inferior vena cava are asymptomatic, and these variants are incidentally detected by computed tomography or magnetic resonance imaging. Their presence may have significant implications for surgery, particularly abdominal surgery in patients with paraaortic lymphadenopathy and in those undergoing laparoscopic radical nephrectomy or inferior vena cava filter placement. We herein discuss the embryology of a double inferior vena cava based on detailed anatomical data of the variations of a double inferior vena cava, including those that require clinical attention.

在2015年为医学生开设的解剖解剖课程中,我们遇到了一例以左下腔静脉为主的双下腔静脉病例。右下腔静脉(正常下腔静脉)宽2.0毫米,左下腔静脉宽23.2毫米。细右下腔静脉始于右髂总静脉,沿腹主动脉右侧上行,然后在第一腰椎下缘水平处与左下腔静脉汇合。占优势的左下腔静脉从左髂总静脉开始,沿腹主动脉左侧上行。大多数双下腔静脉患者都没有症状,这些变异是通过计算机断层扫描或磁共振成像偶然发现的。它们的存在可能对手术有重大影响,尤其是主动脉旁淋巴结病患者和接受腹腔镜根治性肾切除术或下腔静脉滤器置入术的患者的腹部手术。本文根据双下腔静脉变异的详细解剖数据,包括需要临床注意的数据,讨论双下腔静脉的胚胎学。
{"title":"Double Inferior Vena Cava with Major Predominance of the Left Inferior Vena Cava: A Cadaver Case Report.","authors":"Yoko Tabira,&nbsp;Tsuyoshi Saga,&nbsp;Joe Iwanaga,&nbsp;Akihiro Yamashita,&nbsp;Aya Han,&nbsp;Yuto Haikata,&nbsp;Keishiro Kikuchi,&nbsp;Kunimitsu Nooma,&nbsp;Eiko Inoue,&nbsp;Koichi Watanabe","doi":"10.2739/kurumemedj.MS6834013","DOIUrl":"10.2739/kurumemedj.MS6834013","url":null,"abstract":"<p><p>We encountered a case of a double inferior vena cava with major predominance of the left inferior vena cava during an anatomical dissection course for medical students in 2015. The right inferior vena cava (normal inferior vena cava) was 2.0 mm wide, and the left inferior vena cava was 23.2 mm wide. The fine right inferior vena cava began at the right common iliac vein, ascended along the right side of the abdominal aorta, and then joined the left inferior vena cava at the level of the lower margin of the first lumbar vertebra. The dominant left inferior vena cava started from the left common iliac vein and ascended along the left side of the abdominal aorta. Most patients with a double inferior vena cava are asymptomatic, and these variants are incidentally detected by computed tomography or magnetic resonance imaging. Their presence may have significant implications for surgery, particularly abdominal surgery in patients with paraaortic lymphadenopathy and in those undergoing laparoscopic radical nephrectomy or inferior vena cava filter placement. We herein discuss the embryology of a double inferior vena cava based on detailed anatomical data of the variations of a double inferior vena cava, including those that require clinical attention.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"269-275"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9694697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chitinase 3-Like-1 Expression Is Upregulated Under Inflammatory Conditions in Human Oral Epithelial Cells. 人类口腔上皮细胞中几丁质酶3-Like-1的表达在炎症条件下上调。
Q4 Medicine Pub Date : 2023-09-25 Epub Date: 2023-06-29 DOI: 10.2739/kurumemedj.MS6834014
Yui Teratani

Objective: Chitinase 3-like-1 (CHI3L1), also known as YKL-40, is a partially secreted glycoprotein and is involved in inflammatory disorders, including inflammatory bowel diseases. CHI3L1 is known to play a role in biological responses such as cell proliferation, tissue remodeling, and inflammation. CHI3L1 forms an immune complex (known as a Chitosome complex) with IL-13 receptor alpha 2 (IL-13 Rα2) and transmembrane protein 219 (TMEM219) to activate the MAPK/ERK and PKB/AKT signaling pathways. The objective of this study is to investigate how the expressions of CHI3L1 and a Chitosome complex in human oral cavity epithelial cells are linked with intraoral inflammatory diseases.

Method: CHI3L1 and Chitosome complex mRNA expressions were analyzed using human oral squamous cancer cell lines, HSC3 and HSC4 cells. Signaling activation in HSC4 cells was analyzed by using the western blot technique. Immunohistological analysis was performed using surgical samples obtained from patients with benign oral cavity tumors and cysts.

Results: Increased expression of CHI3L1 was observed in both HSC3 and HSC4 cells after TNFα stimulation. The expression of Chitosome complex factors increased as CHI3L1 levels increased, resulting in the activation of a downstream signaling pathway. Among the intraoral tissues, the epithelial cells from inflammatory lesions, but not benign tumors, were found to be intensively stained with the anti-CHI3L1 antibody.

Conclusion: It was indicated that the formation of a Chitosome complex is induced during inflammation, leading to the activation of signaling pathways.

目的:几丁质酶3样-1(CHI3L1),也称为YKL-40,是一种部分分泌的糖蛋白,参与炎症性疾病,包括炎症性肠病。已知CHI3L1在细胞增殖、组织重塑和炎症等生物反应中发挥作用。CHI3L1与IL-13受体α2(IL-13Rα2)和跨膜蛋白219(TMEM219)形成免疫复合物(称为几丁质体复合物),以激活MAPK/ERK和PKB/AKT信号通路。本研究的目的是研究人类口腔上皮细胞中CHI3L1和一种几丁质体复合体的表达如何与口内炎症性疾病有关。方法:应用人口腔鳞状癌症细胞株、HSC3和HSC4细胞,分析CHI3L1和壳体复合体mRNA的表达。用蛋白质印迹技术分析HSC4细胞的信号激活。使用从良性口腔肿瘤和囊肿患者身上获得的手术样本进行免疫组织学分析。结果:TNFα刺激HSC3和HSC4细胞后,CHI3L1表达均增加。随着CHI3L1水平的增加,几丁质酶复合因子的表达增加,导致下游信号通路的激活。在口内组织中,发现来自炎症病变而非良性肿瘤的上皮细胞被抗CHI3L1抗体强烈染色。结论:炎症过程中诱导了一种几丁质复合体的形成,从而激活了信号通路。
{"title":"Chitinase 3-Like-1 Expression Is Upregulated Under Inflammatory Conditions in Human Oral Epithelial Cells.","authors":"Yui Teratani","doi":"10.2739/kurumemedj.MS6834014","DOIUrl":"10.2739/kurumemedj.MS6834014","url":null,"abstract":"<p><strong>Objective: </strong>Chitinase 3-like-1 (CHI3L1), also known as YKL-40, is a partially secreted glycoprotein and is involved in inflammatory disorders, including inflammatory bowel diseases. CHI3L1 is known to play a role in biological responses such as cell proliferation, tissue remodeling, and inflammation. CHI3L1 forms an immune complex (known as a Chitosome complex) with IL-13 receptor alpha 2 (IL-13 Rα2) and transmembrane protein 219 (TMEM219) to activate the MAPK/ERK and PKB/AKT signaling pathways. The objective of this study is to investigate how the expressions of CHI3L1 and a Chitosome complex in human oral cavity epithelial cells are linked with intraoral inflammatory diseases.</p><p><strong>Method: </strong>CHI3L1 and Chitosome complex mRNA expressions were analyzed using human oral squamous cancer cell lines, HSC3 and HSC4 cells. Signaling activation in HSC4 cells was analyzed by using the western blot technique. Immunohistological analysis was performed using surgical samples obtained from patients with benign oral cavity tumors and cysts.</p><p><strong>Results: </strong>Increased expression of CHI3L1 was observed in both HSC3 and HSC4 cells after TNFα stimulation. The expression of Chitosome complex factors increased as CHI3L1 levels increased, resulting in the activation of a downstream signaling pathway. Among the intraoral tissues, the epithelial cells from inflammatory lesions, but not benign tumors, were found to be intensively stained with the anti-CHI3L1 antibody.</p><p><strong>Conclusion: </strong>It was indicated that the formation of a Chitosome complex is induced during inflammation, leading to the activation of signaling pathways.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"221-228"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10070977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Annual Increase of Acute Inpatients with Both Cancer and Cardiovascular Diseases in Japan 2011-2015: Analysis From National Database of Health Insurance Claims and Specific Health Checkups of Japan. 2011-2015年日本癌症和心血管疾病急性住院患者的年增长率:来自日本国家健康保险索赔和特定健康检查数据库的分析。
Q4 Medicine Pub Date : 2023-09-25 Epub Date: 2023-08-07 DOI: 10.2739/kurumemedj.MS6834012
Yume Nohara-Shitama, Kazuo Ishii, Nagisa Morikawa, Shoichiro Nohara, Yoshihiro Fukumoto

Background: Patients with cancer were able to live longer due to improvements in cancer treatment. Additionally, cardiovascular disease (CVD) is the second leading cause of mortality in cancer survivors. However, epidemiological data on onco-CVD have not been sufficiently provided. We aimed to investigate the clinical characteristics of cancer in CVD patients using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB).

Method and results: The NDB sampling dataset used in this study was randomly sampled 10% from the whole Diagnosis Procedure Combination (DPC) records from every January, April, July, and October from 2011 to 2015. The significance of the increase trend in the percentage of records in each disease group to the total number of all DPC records from 2011 to 2015 was checked with Chi-square test with a Bonferroni correction. The percentage of records in cancer with the CVD group to the total number of all DPC records significantly increased over time, and their average age also increased since 2011. Their proportion over 75 years was approximately 56 % in 2015. There was no difference in the cancer sites. However, the prevalence of heart failure dramatically elevated.

Conclusion: We were able to assess the increase in cancer among CVD patients using DPC inpatient records obtained from the NDB. Both cardiologists and oncologists should be more aware of this phenomenon.

背景:由于癌症治疗的改善,癌症患者能够活得更长。此外,心血管疾病(CVD)是癌症幸存者死亡的第二大原因。然而,关于肿瘤CVD的流行病学数据还没有得到充分的提供。我们旨在利用日本国家健康保险索赔和特定健康检查数据库(NDB)调查心血管疾病患者癌症的临床特征。方法和结果:本研究使用的NDB抽样数据集是从2011-2015年每年1月、4月、7月和10月的整个诊断程序组合(DPC)记录中随机抽取10%。从2011年到2015年,每个疾病组的记录百分比占所有DPC记录总数的增加趋势的显著性通过卡方检验和Bonferroni校正进行了检验。随着时间的推移,患有心血管疾病组的癌症记录占所有DPC记录总数的百分比显著增加,自2011年以来,他们的平均年龄也有所增加。2015年,他们在75年内的比例约为56%。癌症部位没有差异。然而,心力衰竭的患病率急剧上升。结论:我们能够使用从NDB获得的DPC住院记录来评估CVD患者中癌症的增加。心脏病专家和肿瘤学家都应该更多地意识到这一现象。
{"title":"Annual Increase of Acute Inpatients with Both Cancer and Cardiovascular Diseases in Japan 2011-2015: Analysis From National Database of Health Insurance Claims and Specific Health Checkups of Japan.","authors":"Yume Nohara-Shitama,&nbsp;Kazuo Ishii,&nbsp;Nagisa Morikawa,&nbsp;Shoichiro Nohara,&nbsp;Yoshihiro Fukumoto","doi":"10.2739/kurumemedj.MS6834012","DOIUrl":"10.2739/kurumemedj.MS6834012","url":null,"abstract":"<p><strong>Background: </strong>Patients with cancer were able to live longer due to improvements in cancer treatment. Additionally, cardiovascular disease (CVD) is the second leading cause of mortality in cancer survivors. However, epidemiological data on onco-CVD have not been sufficiently provided. We aimed to investigate the clinical characteristics of cancer in CVD patients using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB).</p><p><strong>Method and results: </strong>The NDB sampling dataset used in this study was randomly sampled 10% from the whole Diagnosis Procedure Combination (DPC) records from every January, April, July, and October from 2011 to 2015. The significance of the increase trend in the percentage of records in each disease group to the total number of all DPC records from 2011 to 2015 was checked with Chi-square test with a Bonferroni correction. The percentage of records in cancer with the CVD group to the total number of all DPC records significantly increased over time, and their average age also increased since 2011. Their proportion over 75 years was approximately 56 % in 2015. There was no difference in the cancer sites. However, the prevalence of heart failure dramatically elevated.</p><p><strong>Conclusion: </strong>We were able to assess the increase in cancer among CVD patients using DPC inpatient records obtained from the NDB. Both cardiologists and oncologists should be more aware of this phenomenon.</p>","PeriodicalId":39559,"journal":{"name":"Kurume Medical Journal","volume":" ","pages":"209-220"},"PeriodicalIF":0.0,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10000126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Kurume Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1